Epigenetic mechanisms can establish and maintain mitotically stable patterns of gene expression while retaining the DNA sequence. These mechanisms can be affected by environmental factors such as nutrients. The importance of intracellular dosages of nutrient metabolites such as acetyl coenzyme A and S-adenosylmethionine, which are utilized as donors for post-translational modifications, is well-known in epigenetic regulation; however, the significance of indirect metabolites in epigenetic regulation is not clear. In this study, we screened for metabolites that function as epigenetic modulators. Because the expression of genes related to hypothalamic function is reportedly affected by nutritional conditions, we used a neural cell culture system and evaluated hypothalamic-linked loci. We supplemented the culture medium with 129 metabolites separately during induction of human-iPS-derived neural cells and used high-throughput ChIP-qPCR to determine the epigenetic status at 37 hypothalamus-linked loci. We found three metabolites (kynurenine, 3-OH-kynurenine, and anthranilate) from tryptophan pathways that increased H3K4 trimethylation and H2AS40 O-GlcNAcylation, resulting in upregulated gene expression at most loci, except those encoding panneural markers. Dietary supplementation of these three metabolites and the resulting epigenetic modification were important for stability in gene expression. In conclusion, our findings provide a better understanding of how nutrients play a role in epigenetic mechanisms.
Results
Kynurenine, 3-OH-kynurenine, and anthranilate exert epigenetic effects on hypothalamic neural genes. The differentiated hiPSCs reportedly complete neural commitment at day 14 and then reach neurons expressing pan-neural markers such as TUBB3 and MAP2 at day 20 16, 23 . To avoid suppressing the neural commitment of hiPSCs and to evaluate the effect of metabolites on neurons, 129 commercially available metabolites were individually added to the medium from day 14 until day 24 of culturing (Table 1 and Supplementary  Table 1 ). Cells were collected on day 24 of culture to determine H3K4me3 and H2AS40Gc levels around the transcriptional start site (Fig. 1a ). We selected the SDIA neural differentiation method to induce dopaminergic neurons from hiPSCs, rather than hypothalamic neurons 16, 23 . This choice allowed us to better estimate the effects of metabolites on epigenetic activation at hypothalamic neural peptide-coding and differentiation-related loci. Before beginning epigenetic analysis, we confirmed via bright-field microscopy that for each metabolite, supplementation was not associated with a significant reduction in cells.
We used principal component analysis (PCA) to analyze ChIP-qPCR data of H3K4me3 and H2AS40Gc at 37 loci (23 hypothalamic neuropeptide-coding genes and 14 neural differentiation-related genes) (Fig. 1b,c) . The PC1-PC2 and PC1-PC3 plots revealed that treatment with four metabolites (succinyl-CoA, anthranilate, 3-OH-kynurenine, and kynurenine) resulted in markedly different H3K4me3 levels (Fig. 1b) . Furthermore, the PC1-PC2 and PC1-PC3 axes respectively identified seven (creatine, anthranilate, TMP, AMP, isocitrate, kynurenine, and 3-OH-kynurenine) and six metabolites (3-OH-kynurenine, kynurenine, isocitrate, anthranilate, TMP, and AMP) that markedly changed H2AS40Gc levels ( Fig. 1c) . Notably, kynurenine, 3-OH-kynurenine, and anthranilate were common in both types of histone modification. Therefore, subsequent analyses focused on the effects of these three metabolites. Heatmap visualizations of ChIP-qPCR data showed that both types of histone modification increased with supplementation of kynurenine, 3-OH-kynurenine, and anthranilate at nearly every included locus ( Fig. 2a,b) , in a dose-dependent manner ( Fig. 2c,d ). The only exception was at genes encoding pan-neural markers (TUBB3 and MAP2), suggesting a locus specificity to the metabolites' effects.
Next, the results of RT-qPCR assays for 17 hypothalamic neuropeptide-coding genes revealed a significant, dose-dependent increase in gene expression (except of KISS1) in neurons supplemented with the three metabolites ( Fig. 3a ). Immunofluorescence assays detected more GHRH, CARTPT, NPY, AGRP, CRH, and TRH-positive cells in TUBB3-positive colonies that differentiated in the presence of kynurenine, 3-OH-kynurenine, and anthranilate than in non-treated cells (Fig. 3b ). Epigenetic mechanisms support stable gene activation, thus allowing for specific functions in distinct cell types 1,2 . We cultured cells for 9 days without metabolites to clarify whether epigenetic changes did indeed result in gene upregulation (Fig. 6a ). During this period, six genes (CARTPT, CRH, OXT, PDYN, POMC, and GAST) www.nature.com/scientificreports www.nature.com/scientificreports/ maintained the same expression in cells supplemented with kynurenine, 3-OH-kynurenine, and anthranilate ( Fig. 6b ). However, in quinolinate-supplemented cells, the expression of these genes dropped quickly. The pan-neural marker genes TUBB3 and MAP2 did not exhibit these differences between culture conditions. Collectively, these data show that the three metabolites (kynurenine, 3-OH-kynurenine, and anthranilate) were necessary for epigenetic activation (H3K4me3 and H2AS40Gc). Moreover, these epigenetic changes are necessary for the maintenance of stable gene expression.
Kynurenine, 3-OH-kynurenine, and anthranilate did not affect the expression of genes involved in histone modification and NAD production. To understand the mechanisms underlying kynurenine-induced epigenetic activation, we analyzed the expression of genes encoding histone modification enzymes in neurons supplemented with kynurenine, 3-OH-kynurenine, and anthranilate. We also measured the intracellular NAD+ and NADH concentrations in these cells. We did not find significant metabolite-related changes in the expression of genes coding enzymes for H3K4me3 (17 genes) or O-GlcNAcylation (two genes) ( Fig. 7a ). We also examined the genes associated with repressed histone modification H3K27me3 (six genes) and histone acetylation (19 genes) because multiple layers of epigenetic regulatory controls involving histone modifications are involved in the establishment, maintenance, and heritability of gene expression 26, 27 . We also looked for and did not find any metabolite-induced changes in these genes.
NAD+ is an activator of sirtuins, a group of molecules that function as histone de-acetylases 28, 29 . Therefore, cellular NAD+ concentration and NAD+/NADH balance are important for histone acetylation, indirectly leading to kynurenine-dependent epigenetic activation. We measured NAD+ and NADH concentrations in cells supplemented with kynurenine, 3-OH-kynurenine, and anthranilate, using NAD-supplemented cells as a positive control. We found that intracellular NAD+ and NADH concentrations did not significantly change in cells treated with the three metabolites ( Fig. 7b ).
Discussion
We successfully demonstrated that metabolites kynurenine, 3-OH-kynurenine, and anthranilate activate histone modifications at loci encoding hypothalamic neural peptides and differentiation-related factors. Further, these epigenetic modifications were associated with gene expression and necessary for the maintenance of stable gene expression. Previous reports examining the link between epigenetics and nutrition have tended to focus on one-carbon metabolism, glycolysis, and acyl-CoA metabolism, which directly provides SAM and acetyl-CoA for protein methylation and acetylation, respectively 30, 31 . Our study added to these findings by showing that metabolites not directly involved in epigenetic modifications can also influence epigenetic status.
In this study, we used a ChIP-qPCR assay to estimate locus-specific epigenetic alterations. We chose not to use whole-measurement methods such as western blots. Although previous studies indicated that intracellular concentrations of epigenetic factors (e.g., acetyl-CoA and SAM) affected global modification levels 5, 32 , this occurred in a locus-specific manner 33, 34 . Our previous study also indicated that ManNAc activated only HCRT and not www.nature.com/scientificreports www.nature.com/scientificreports/ other loci coding hypothalamic neural peptides 15, 16 . Our decision to use locus-specific methods allowed us to better identify the link between individual metabolites (kynurenine, 3-OH-kynurenine, anthranilate) and a given locus. By changing the gene set and cell type in each experiment, our method could find metabolites that alter epigenetic status in a cell-type-and gene-specific manner.
The essential amino acid tryptophan is either used for protein synthesis or metabolized into bioactive molecules via the KP or serotonin pathway; these processes account for over 95% of dietary tryptophan 24, 25 . Most KP metabolites are neuroactive, with essential roles in regulating N-methyl-D-aspartate (NMDA) receptor function and free-radical production 35 . Since NMDA receptor-mediated excitotoxicity and excessive free-radical production are involved in neurodegenerative disorders, including Huntington's, Parkinson's, and Alzheimer's diseases, preclinical studies are investigating pharmacological modulation of this pathway 36, 37 . Although research has shown that kynurenine and 3-OH-kynurenine concentrations are elevated in the cerebrospinal fluid of patients with neurological diseases 38, 39 , the link between altered metabolite levels and disease development remains unclear. Given that kynurenine can alter epigenetic status in addition to regulating NMDA receptor function, our findings provide new insight on how KP metabolites could cause some neurological disorders. In the present study, we fixed the metabolite supplementation time at 10 days. To determine the link between the epigenetic function of KP metabolites and disease development, it may also be important to understand the timing and duration of metabolite exposure needed for altering epigenetic status. Future time-course experiments on neurons can help validate this hypothesis.
Here, we mainly focused on the effects of kynurenine, 3-OH-kynurenine, and anthranilate because they elevated both H3K4me3 and H2AS40Gc levels. However, we found that supplementation with succinyl-CoA increased H3K4me3 levels, while supplementation with isocitrate, AMP, and TMP increased H2AS40Gc levels. Succinyl-CoA, isocitrate, and AMP have been linked to epigenetic regulation. Instrumental in tumor development, succinyl-CoA is involved in histone succinylation through the action of lysine acetyltransferase 2A (KAT2A) 40 . Isocitrate is a precursor of α-KG, a metabolic intermediate that acts as a cofactor for several chromatin-modifying enzymes, including histone demethylases and TET enzymes 41 . Lastly, AMP triggers AMP-activated kinase (AMPK), a master regulator of energy homeostasis, as well as a key mediator of adaptation and cell survival through phosphorylation of histones, DNA methyltransferases, and histone modifiers 42, 43 . All of these metabolites might have influenced H3K4me3 or H2AS40Gc levels, however, further research is needed to clarify the exact mechanism through which the metabolites influence H3K4me3 or H2AS40Gc.
Here, we investigated whether kynurenine supplementation would indirectly affect expression of epigenetic factors and intracellular NAD+ concentration. However, we could not determine the mechanisms from our results. Previous reports suggest that kynurenine binds to the transcription factor aryl hydrocarbon receptor (AhR), inducing its translocation from the cytoplasm to the nucleus 44 . AhR is implicated in multiple cellular processes, including embryogenesis, tumorigenesis, and inflammation 45, 46 . Moreover, AhR regulates the expression of genes encoding epigenetic factors such as HDAC8 47 . However, supplementation with kynurenine, 3-OH-kynurenine, and anthranilate did not affect HDAC gene expression in this study. Currently, we lack a clear understanding of AhR as an epigenetic factor, nor are data available on the binding potency of 3-OH-kynurenine and anthranilate to AhR. We recommend further studies focusing on AhR to determine whether it is a key player in epigenetic activation through supplementation of kynurenine, 3-OH-kynurenine, and anthranilate.
Key questions for the future include delineating the mechanisms underlying activation of epigenetic status by kynurenine at specific loci and regulation of nuclear events. Metabolic enzymes may adjust gene transcription in response to changes in metabolic state, although few studies have provided empirical evidence of this phenomenon. Fumarase, an enzyme normally associated with oxidative metabolism in the mitochondria, is localized in the nucleus through interacting with histone variant H2AZ, and regulates both histone methylation and DNA double-strand break repair 48 . An enzyme involved in SAM production, MAT2A also localizes to the nucleus and is associated with transcriptional repression of COX2, a process mediated by H3K9 methylation through the action of methyltransferase SETDB1 34 . Although traditionally located in the mitochondria, the pyruvate dehydrogenase complex can move to the nucleus, where it generates high acetyl-CoA concentrations to fuel histone acetylation, required for gene expression during the S phase 49 . According to the Human Protein Atlas (https:// www.proteinatlas.org/) 50 , enzymes involved in kynurenine, 3-OH-kynurenine, and anthranilate metabolism (e.g., Figure 6 . Epigenetic activation by kynurenine, 3-OH-kynurenine, and anthranilate is necessary for maintenance of expression of hypothalamic neural peptide-coding genes. (a) Culture protocol for analyzing gene expression in long-term-cultured cells. Kynurenine, 3-OH-kynurenine, anthranilate, and quinolinate (all 100 μM) were added on day 14. Culturing continued until day 24, followed by 9 days of culture without metabolites. (b) Neural peptide-coding gene expression, evaluated with RT-qPCR, in neurons cultured without metabolites for 9 days. Means ± SD (n = 3). TUBB3 and MAP2 were used as pan-neural markers.
www.nature.com/scientificreports www.nature.com/scientificreports/ KYNU and KYAT1) are localized to the cytoplasm and nucleoplasm ( Supplementary Fig. 2 ). Experimental findings confirm that tryptophan degradation during KP occurs in the cytoplasm 24, 25 . These data suggest that nuclear localization of KYNU or KYAT can dramatically affect chromatin structure by change in metabolism, resulting in epigenetic changes and regulation of gene expression. KYNU and KYAT are of particular interest because as of now, there are no reports on the relationship between kynurenine metabolism and epigenetic systems such as H3K4me3 and H2AS40Gc; therefore, the mechanisms underlying kynurenine-dependent epigenetic alterations are unknown. However, nucleus-localized KYNU and KYAT could be key factors in understanding those mechanisms. To clarify the mechanisms, future studies should analyze the physiological functions of these epigenetic regulation-related enzymes and their partner proteins.
In conclusion, the present study, which screened metabolites capable of altering the epigenetic status at specific loci, indicated that kynurenine, 3-OH-kynurenine, and anthranilate function to activate epigenetic status involved in induction/maintenance of gene expression. Our results will provide a new insight for controlling cell fate and disease progression by exploiting the epigenetic modulation ability of these metabolites.
Materials and Methods
Reagents. Unless otherwise noted, reagents were purchased from Wako Pure Chemical (Japan). Metabolites used in this study are listed in Supplementary Table 1 . All primers were prepared by Sigma or FASMAC; their sequences are shown in Supplementary Table S2 . Antibodies are listed in Supplementary Table S3 .
Neural differentiation from hiPSCs. The hiPSC line 201B7 was provided by RIKEN BRC, through the National Bio-Resource Project of the MEXT, Japan 51 . Cells were maintained on layers of mitomycin C-treated STO/Neo resistant/LIF (SNL) feeder cells in ReproStem medium (ReproCELL, Japan) supplemented with 5 ng/ mL bFGF. Neural differentiation using SDIA methods was performed as described in the previous reports 23 . 
